Suchergebnisse - "Chen, Xianguo"

PubPharm (76)

1

Sodium butyrate alleviates experimental autoimmune prostatitis by inhibiting oxidative stress and NLRP3 inflammasome activation via the Nrf2/HO-1 pathway

enthalten in: The Prostate | 2024

von Hua, X. | Zhang, J. | Chen, J. | +6

2

The causative effect of CXCR7 on experimental autoimmune prostatitis injury and fibrosis

enthalten in: ResearchSquare.com | 2024

von zhang, Y. | Feng, R. | Wu, W. | +5

3

Angiogenesis-relevant lncRNA signature for osteosarcoma: prospects for prediction of clinical outcomes and immunotherapeutic efficacy

enthalten in: ResearchSquare.com | 2023

von Chen, X. | Lin, Z. | Chen, Y. | +2

4

Carbonic Anhydrase 4 Serves as A Novel Prognostic Biomarker and Therapeutic Target for Non-Small Cell Lung Cancer : A Study Based on TCGA Samples

enthalten in: Combinatorial chemistry & high throughput screening | 2023

von Xu, B. | Lou, Y. | Xu, X. | +4

5

Dietary habits and lifestyle related to the effectiveness of low-intensity extracorporeal shock wave therapy for chronic prostatitis/chronic pelvic pain syndrome-like symptoms : Initial results

enthalten in: Andrologia | 2022

von Bian, Z. | Jin, C. | Mo, F. | +8

6

CXCR3 antagonist AMG487 ameliorates experimental autoimmune prostatitis by diminishing Th1 cell differentiation and inhibiting macrophage M1 phenotypic activation

enthalten in: The Prostate | 2022

von Hua, X. | Zhang, J. | Ge, S. | +7

7

Correction : Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

enthalten in: Molecular cancer | 2022

von Li, H. | Yu, G. | Shi, R. | +9

ErratumFor: Mol Cancer. 2014 Jan 15;13:8. - PMID 24423412

8

Correction: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

enthalten in: Molecular cancer | 2022

von Li, H. | Yu, G. | Shi, R. | +9

9

A novel RET fusion in non-small cell lung cancer identified by next-generation sequencing : a case report

enthalten in: Journal of cancer research and clinical oncology | 2022

von Xu, X. | Wang, H. | Yu, Z. | +1

10

Identification of novel susceptibility factors related to CP/CPPS-like symptoms : Evidence from a multicenter case-control study

enthalten in: The Prostate | 2022

von Zhang, M. | Jin, C. | Kong, X. | +15

1
2
3
4
5
6
7
8
Nächster »
[8]